Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 1
1979 1
1980 1
1982 1
1983 2
1984 4
1985 3
1986 5
1987 2
1988 3
1989 2
1990 4
1991 8
1992 6
1993 3
1994 4
1995 8
1996 4
1997 7
1998 5
1999 8
2000 6
2001 4
2002 1
2003 8
2004 11
2005 12
2006 4
2007 3
2008 4
2009 5
2010 5
2011 4
2012 2
2013 3
2014 5
2015 9
2016 19
2017 11
2018 8
2019 5
2020 16
2021 10
2022 7
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

231 results

Results by year

Filters applied: . Clear all
Page 1
Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279.
Leit S, Greenwood J, Carriero S, Mondal S, Abel R, Ashwell M, Blanchette H, Boyles NA, Cartwright M, Collis A, Feng S, Ghanakota P, Harriman GC, Hosagrahara V, Kaila N, Kapeller R, Rafi SB, Romero DL, Tarantino PM, Timaniya J, Toms AV, Wester RT, Westlin W, Srivastava B, Miao W, Tummino P, McElwee JJ, Edmondson SD, Masse CE. Leit S, et al. Among authors: edmondson sd. J Med Chem. 2023 Aug 10;66(15):10473-10496. doi: 10.1021/acs.jmedchem.3c00600. Epub 2023 Jul 10. J Med Chem. 2023. PMID: 37427891
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs.
Johannes JW, Balazs A, Barratt D, Bista M, Chuba MD, Cosulich S, Critchlow SE, Degorce SL, Di Fruscia P, Edmondson SD, Embrey K, Fawell S, Ghosh A, Gill SJ, Gunnarsson A, Hande SM, Heightman TD, Hemsley P, Illuzzi G, Lane J, Larner C, Leo E, Liu L, Madin A, Martin S, McWilliams L, O'Connor MJ, Orme JP, Pachl F, Packer MJ, Pei X, Pike A, Schimpl M, She H, Staniszewska AD, Talbot V, Underwood E, Varnes JG, Xue L, Yao T, Zhang K, Zhang AX, Zheng X. Johannes JW, et al. Among authors: edmondson sd. J Med Chem. 2021 Oct 14;64(19):14498-14512. doi: 10.1021/acs.jmedchem.1c01012. Epub 2021 Sep 27. J Med Chem. 2021. PMID: 34570508
The Evidence for Adjunctive Facelift Procedures.
Urso-Baiarda F, Edmondson SJ, Grover R. Urso-Baiarda F, et al. Among authors: edmondson sj. Facial Plast Surg. 2018 Dec;34(6):624-630. doi: 10.1055/s-0038-1675750. Epub 2018 Dec 28. Facial Plast Surg. 2018. PMID: 30593078 Review.
Reply: Robin Sequence: 5-Year Speech Outcomes-A Case-Control Study.
Schwaiger M, Edmondson SJ, Wallner J, Ferguson L. Schwaiger M, et al. Among authors: edmondson sj. Plast Reconstr Surg. 2022 Aug 1;150(2):481e-482e. doi: 10.1097/PRS.0000000000009311. Epub 2022 Jun 17. Plast Reconstr Surg. 2022. PMID: 35708674 No abstract available.
Novel potent and selective pyrazolylpyrimidine-based SYK inhibitors.
Barlaam B, Boiko S, Boyd S, Dry H, Gingipalli L, Ikeda T, Johnson T, Kawatkar S, Lorthioir O, Pike A, Pollard H, Read J, Su Q, Wang H, Wang H, Wang L, Wang P, Edmondson SD. Barlaam B, et al. Among authors: edmondson sd. Bioorg Med Chem Lett. 2020 Nov 15;30(22):127523. doi: 10.1016/j.bmcl.2020.127523. Epub 2020 Aug 30. Bioorg Med Chem Lett. 2020. PMID: 32877741
Robin Sequence: 5-Year Speech Outcomes-A Case-Control Study.
Schwaiger M, Cook H, Jordan Z, Edmondson SJ, Mischak I, Wallner J, Atherton D, Haers P, Timoney N, Ferguson L. Schwaiger M, et al. Among authors: edmondson sj. Plast Reconstr Surg. 2021 Mar 1;147(3):676-686. doi: 10.1097/PRS.0000000000007641. Plast Reconstr Surg. 2021. PMID: 33587554
231 results